ACETAdicet BioACET info
$1.50info0.00%24h
Global rank23710
Market cap$64.75M
Change 7d4.17%
YTD Performance-20.63%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Adicet Bio (ACET) Stock Overview

    Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and chimeric adaptors to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also develops ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors; and ADI-925, a novel engineered CAd gamma delta T cell product candidate targeting tumor stress ligands. Adicet Bio, Inc. is based in Boston, Massachusetts.

    ACET Stock Information

    Symbol
    ACET
    Address
    200 Berkeley StreetBoston, MA 02116United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.adicetbio.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    650 503 9095

    Adicet Bio (ACET) Price Chart

    -
    Value:-

    Adicet Bio Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.50
    N/A
    Market Cap
    $64.75M
    N/A
    Shares Outstanding
    43.16M
    N/A
    Employees
    132.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org